Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Pfizer (NY:PFE)

22.83 +0.23 (+1.02%)
Official Closing Price Updated: 7:00 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
99 100 Next >
2 Ultra-High-Yield Dividend Stocks That Are No-Brainer Buys in February
These sensational income stocks -- sporting an average yield of 6.15% -- can fatten investors' pocketbooks for a long time to come. 
Via The Motley Fool
Dow Trims Losses After Trump Delays Mexico, Canada Tariffs: Greed Index Remains In 'Fear' Zone
Via Benzinga
Topics Government Stocks
Exposures Political US Equities
Pfizer Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Via Benzinga
PepsiCo, Pfizer And 3 Stocks To Watch Heading Into Tuesday
US stock futures down on Tues, focus on PepsiCo, NXP Semiconductors, Pfizer earnings. UBS reports strong Q4, EA to release after market close. 
Via Benzinga
Here’s What NOT to Do the Next Time Tariffs Hit
Worried about market drops and tariff news? Discover why short-term volatility shouldn’t derail your long-term investing strategy, with lessons from Amazon and other market giants. Stay focused on... 
Via InvestorPlace
Topics World Trade
Exposures Tariff
Peering Into Pfizer's Recent Short Interest
Via Benzinga
Pfizer Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Via Benzinga
Earnings Scheduled For February 4, 2025
Via Benzinga
Which S&P500 stocks are the most active on Monday?
Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest. 
Via Chartmill
Merck Vs. Pfizer: Which Pharmaceutical Giant Will Prevail In Q4 Earnings?
Merck and Pfizer are heading into fourth quarter earnings with different technical setups, leaving investors unsure of which stock will prevail. While Merck shows short-term strength, Pfizer is... 
Via Benzinga
Activist Starboard Value Pushes Becton Dickinson To Divest Life Sciences Unit
Activist investor Starboard Value is urging Becton Dickinson to sell its life sciences division, citing potential value gains. Analysts estimate a spin-off could boost the company's worth by up to... 
Via Benzinga
Pfizer Trial For Colorectal Cancer Treatment Shows Improved Survival In Late-Stage Study
Pfizer's Braftovi combination showed significant survival benefits in a Phase 3 study for BRAF V600E-mutant metastatic colorectal cancer. 
Via Benzinga
Pfizer’s BRAFTOVI® Combination Regimen Significantly Improved Progression-Free Survival and Overall Survival in Phase 3 BREAKWATER Trial
From Pfizer Inc.
Via Business Wire
Pfizer's Options: A Look at What the Big Money is Thinking
Via Benzinga
Better Artificial Intelligence Stock: SoundHound AI vs. Palantir Technologies
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Current Report: Viatris Inc
Viatris Inc. is a wholly owned subsidiary of Pfizer that specializes in off-patent drugs. Share price fell about 4% in the past year from $11.88 to $11.41, as of Thursday’s market close. 
Via Talk Markets
Topics Stocks / Equities
RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders
Kennedy seeks to be Secretary of Health and Human Services — a position that would put him in charge of the health of the American people. 
Via Benzinga
Topics Government
Exposures Political
Robert Kennedy Jr. Faces Senate Confirmation Hearings As Bird Flu Concerns Grow: Caroline Kennedy Says Cousin 'Predator' Unfit For Office
Robert F. Kennedy, Jr. will begin Senate confirmation hearings on Wednesday as President Donald Trump's pick to lead the Department of Health and Human Services. 
Via Benzinga
Topics Government
Exposures Political
Market Alert: PESG Releases New Report Highlighting Silexion Therapeutics as an Emerging Leader in the Multi-Billion Dollar Precision Oncology Industry
Market Alert: PESG Releases New Report Highlighting Silexion Therapeutics as an Emerging Leader in the Multi-Billion Dollar Precision Oncology Industry 
Via News Direct
The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senate Hearings
The Senate will meet Wednesday to start the confirmation hearing process for Robert F. Kennedy Jr. 
Via Investor's Business Daily
Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium
From Pfizer Inc.
Via Business Wire
I Own 4 High-Yield Dividend Stocks. Here's Why I Own Each One.
Via The Motley Fool
Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm?
The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health Organization on Monday, marking a dramatic acceleration of President Donald... 
Via Benzinga
Topics Government
Exposures Political
Pfizer's Conditionally Approved Braftovi Combo Therapy Regime Shows Improved Response In Colorectal Cancer Patients
Pfizer's Phase 3 BREAKWATER trial showed Braftovi combo improved response rates and duration in BRAF V600E-mutant metastatic colorectal cancer. 
Via Benzinga
What's Going On With Pfizer Stock Monday?
Pfizer Inc (NYSE:PFE) shares are trading higher Monday. Some of the optimism may be surrounding activist Starboard Value's decision to not pursue a proxy battle with the company. 
Via Benzinga
Pfizer Jumps After Avoiding Proxy Fight With Activist Investor Starboard — For Now
Pfizer made a promising move Monday after the deadline passed for Starboard to nominate board members. 
Via Investor's Business Daily
Biotech And Healthcare Stocks Poised For Gains Ahead
The XLV bounced off the bottom this month up 4% to the $144 level led by biopharma and medtech. 
Via Talk Markets
Topics ETFs Stocks / Equities
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
JD Vance: 'Prices Are Going To Come Down, But It's Going To Take Time,' As Trump's Energy Policies Start To Take Effect
U.S. Vice President JD Vance acknowledged Sunday that Americans will need to wait before seeing relief from high grocery prices, despite the President Donald Trump administration's flurry of executive... 
Via Benzinga
Topics Government
Exposures Political
Financial Crime Weekly: Pfizer Pays Nearly $60 Million To Resolve False Claims Allegations, SEC Creates Crypto Task Force
The DOJ announces Pfizer agreed to pay nearly $60 million to resolve false claims allegations. The SEC creates a task force dedicated to the development of a clear and comprehensive regulatory... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.